Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
185M
Number of holders
28
Total 13F shares, excl. options
3.03M
Shares change
+182K
Total reported value, excl. options
$30.9M
Value change
+$1.76M
Number of buys
15
Number of sells
-15
Price
$10.19

Significant Holders of HUMACYTE, INC. - Common Stock, par value $0.0001 per share (AHAC) as of Q2 2021

37 filings reported holding AHAC - HUMACYTE, INC. - Common Stock, par value $0.0001 per share as of Q2 2021.
HUMACYTE, INC. - Common Stock, par value $0.0001 per share (AHAC) has 28 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 3.03M shares of 185M outstanding shares and own 1.64% of the company stock.
Largest 10 shareholders include Maven Securities LTD (500K shares), Tudor Investment Corp Et Al (403K shares), UBS OCONNOR LLC (300K shares), Altium Capital Management LP (275K shares), COWEN AND COMPANY, LLC (241K shares), Alpine Global Management, LLC (210K shares), Eversept Partners, LP (205K shares), P SCHOENFELD ASSET MANAGEMENT LP (200K shares), Omni Partners US LLC (192K shares), and TENOR CAPITAL MANAGEMENT Co., L.P. (100K shares).
This table shows the top 28 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.